Skip to main content
Clinical Trials/NCT04767685
NCT04767685CompletedNot Applicable

The Bern Perioperative Biobank to Define Perioperative Changes of Molecular Markers of Perioperative Organo-dysfunctions, Inflammation, Adverse Events and Disease Progression

Insel Gruppe AG, University Hospital Bern1 site in 1 country547 target enrollmentStarted: January 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
547
Locations
1
Primary Endpoint
Assessing the change of the metabolic profile in the perioperative setting

Study Overview

Brief Summary

The goal of the research is to define clinically relevant molecular markers for increased risk of peri-/ postoperative organo-dysfunctions, inflammation, adverse events and disease progression. To better understand the perioperative impact the investigators aim to determine perioperative levels of molecular markers over time in the available samples and clinical data of the Bern perioperative Biobank (BPBB) cohort to finally increase quality of perioperative care of patients by permitting preventive measures to be taken early in patients at risk.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 years and older
  • Written informed consent
  • Non-emergency surgery
  • Exclusion Criteria
  • Transient incapacity to consent or insufficient time (< 6h) to consider study participation
  • No informed consent
  • Cognitive impairment/Patients unable to consent
  • Patients who retrospectively expressed their wish to be excluded

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Assessing the change of the metabolic profile in the perioperative setting

Time Frame: On postoperative day 1 during the morning round between 07:30-9:00am

Surgery causes significant disruption of physiologic metabolism. The investigators currently lack specific markers to assess change of the metabolic profile in the perioperative setting. The investigators aim to identify metabolic markers and their change in the perioperative period in association with patients' clinical outcome.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials